Respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD) often require a dual-acting therapy that can provide both rapid symptom relief and long-term inflammation control.
BUDESHINE F 200 is a scientifically advanced inhalation therapy that combines Formoterol Fumarate (a long-acting bronchodilator) and Budesonide (a corticosteroid). This dual formulation is designed to target the root causes of breathing difficulties—airway inflammation and bronchoconstriction—providing patients with improved lung function, reduced symptoms, and better quality of life.
Composition
Each dose of BUDESHINE F 200 contains:
Formoterol Fumarate – A long-acting β2-adrenergic agonist (LABA)
Budesonide 200 mcg – An inhaled corticosteroid (ICS)
Mechanism of Action
Formoterol Fumarate
Acts as a long-acting bronchodilator.
Stimulates β2-receptors in the airway smooth muscle, leading to relaxation and widening of bronchial passages.
Provides rapid onset (within minutes) and sustained action for up to 12 hours, ensuring long-lasting relief from breathlessness and wheezing.
Budesonide
A potent corticosteroid with powerful anti-inflammatory properties.
Reduces swelling, irritation, and mucus production in the airways.
Helps prevent asthma attacks and COPD exacerbations when used regularly.
👉 Together, this combination ensures symptom relief, prevention of flare-ups, and long-term disease control.
Therapeutic Indications
BUDESHINE F 200 is prescribed for:
Asthma – maintenance therapy for patients requiring both a bronchodilator and corticosteroid.
Chronic Obstructive Pulmonary Disease (COPD) – including chronic bronchitis and emphysema.
Prevention of Exercise-Induced Bronchospasm (when used as maintenance therapy).
Dosage and Administration
Typical Adult Dose: 1 inhalation twice daily, or as directed by a physician.
Route: Oral inhalation using a dry powder inhaler device.
Important: Not meant for acute asthma attacks—patients should keep a short-acting bronchodilator (rescue inhaler) for emergencies.
Key Benefits of BUDESHINE F 200
✔ Dual Action Therapy: Combines bronchodilation and anti-inflammatory control.
✔ Rapid Relief + Long-Term Protection: Works within minutes and lasts up to 12 hours.
✔ Improved Lung Function: Enhances airflow and reduces breathing difficulties.
✔ Reduces Exacerbations: Prevents frequent asthma and COPD flare-ups.
✔ Better Patient Compliance: Convenient combination in a single inhalation.
Possible Side Effects
Like all inhaled therapies, BUDESHINE F 200 may cause some mild side effects, including:
Throat irritation or cough
Hoarseness of voice
Oral thrush (fungal infection)
Headache or dizziness
Rarely, palpitations or tremors
Tip: Rinsing the mouth after each inhalation reduces the risk of oral thrush and throat irritation.
Precautions & Warnings
Not for emergency relief of acute asthma symptoms.
Use cautiously in patients with heart disease, hypertension, diabetes, or thyroid disorders.
Monitor growth in children on long-term therapy.
Pregnant or breastfeeding women should use only under medical supervision.
Regular medical follow-up is essential for patients on chronic therapy.
Storage
Store in a cool, dry place, away from direct sunlight.
Keep the inhaler tightly closed after use.
Keep out of reach of children.
Conclusion
Formoterol Fumarate and Budesonide Powder for Inhalation is a reliable, evidence-based therapy for patients suffering from asthma and COPD. With its dual-action approach, it not only relieves bronchospasm but also reduces underlying airway inflammation—ensuring both immediate comfort and long-term disease management.
By improving lung function, reducing flare-ups, and providing 12-hour protection, BUDESHINE F 200 empowers patients to breathe freely and live more actively.
